Global Neurocutaneous Disorder Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 119 pages | ID: G6EEC1AC8A3GEN
GlobalInfoResearch

Abstracts

Neurocutaneous Disorders are disorders that lead to growth of tumors in various parts of the body. They're caused by the abnormal development of cells in an embryo and characterized by the tumors in various parts of the body (including the nervous system) and by certain differences in the skin. While some can be diagnosed at birth, others don't produce symptoms until later in life. Although neurocutaneous disorders can't be cured, treatments can help manage symptoms and any health problems that occur.

SCOPE OF THE REPORT:

This report studies the Neurocutaneous Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neurocutaneous Disorder market by product type and applications/end industries.
Common neurocutaneous disorders that affect kids include neurofibromatosis, sturge-Weber syndrome, tuberous sclerosis (TS), ataxia-telangiectasia (A-T) and von Hippel-Lindau disease (VHL). Symptoms vary widely from condition to condition, and they affect different kids in different ways. Often, the full effects of these diseases ? even if detected at birth ? don't emerge until a child grows up. The educational, social, and physical problems that the conditions cause must be managed throughout a child's life.
The global Neurocutaneous Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neurocutaneous Disorder.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Valeant Pharmaceuticals
• Allergan
• Syneron Medical
• Medtronic
• Cutera
• St Jude Medical
• Pfizer

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Tuberous Sclerosis (TS)
• Neurofibromatosis (NF)
• Sturge-Weber Syndrome Disease
• Von Hippel-Lindau Disease (VHL)
• Ataxia-Telangiectasia (A-T)

Market Segment by Applications, can be divided into

• Hospital & Clinics
• Diagnostic Centers

Contents

1 NEUROCUTANEOUS DISORDER MARKET OVERVIEW

1.1 Product Overview and Scope of Neurocutaneous Disorder
1.2 Classification of Neurocutaneous Disorder by Types
  1.2.1 Global Neurocutaneous Disorder Revenue Comparison by Types (2017-2023)
  1.2.2 Global Neurocutaneous Disorder Revenue Market Share by Types in 2017
  1.2.3 Tuberous Sclerosis (TS)
  1.2.4 Neurofibromatosis (NF)
  1.2.5 Sturge-Weber Syndrome Disease
  1.2.6 Von Hippel-Lindau Disease (VHL)
  1.2.7 Ataxia-Telangiectasia (A-T)
1.3 Global Neurocutaneous Disorder Market by Application
  1.3.1 Global Neurocutaneous Disorder Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital & Clinics
  1.3.3 Diagnostic Centers
1.4 Global Neurocutaneous Disorder Market by Regions
  1.4.1 Global Neurocutaneous Disorder Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Neurocutaneous Disorder Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Neurocutaneous Disorder Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurocutaneous Disorder Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Neurocutaneous Disorder Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurocutaneous Disorder Status and Prospect (2013-2023)
1.5 Global Market Size of Neurocutaneous Disorder (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Valeant Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Neurocutaneous Disorder Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Valeant Pharmaceuticals Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
  2.2.1 Business Overview
  2.2.2 Neurocutaneous Disorder Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Allergan Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.3 Syneron Medical
  2.3.1 Business Overview
  2.3.2 Neurocutaneous Disorder Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Syneron Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.4 Medtronic
  2.4.1 Business Overview
  2.4.2 Neurocutaneous Disorder Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Medtronic Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cutera
  2.5.1 Business Overview
  2.5.2 Neurocutaneous Disorder Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Cutera Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.6 St Jude Medical
  2.6.1 Business Overview
  2.6.2 Neurocutaneous Disorder Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 St Jude Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
  2.7.1 Business Overview
  2.7.2 Neurocutaneous Disorder Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Pfizer Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL NEUROCUTANEOUS DISORDER MARKET COMPETITION, BY PLAYERS

3.1 Global Neurocutaneous Disorder Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Neurocutaneous Disorder Players Market Share
  3.2.2 Top 10 Neurocutaneous Disorder Players Market Share
3.3 Market Competition Trend

4 GLOBAL NEUROCUTANEOUS DISORDER MARKET SIZE BY REGIONS

4.1 Global Neurocutaneous Disorder Revenue and Market Share by Regions
4.2 North America Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
4.3 Europe Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
4.5 South America Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA NEUROCUTANEOUS DISORDER REVENUE BY COUNTRIES

5.1 North America Neurocutaneous Disorder Revenue by Countries (2013-2018)
5.2 USA Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
5.3 Canada Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
5.4 Mexico Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

6 EUROPE NEUROCUTANEOUS DISORDER REVENUE BY COUNTRIES

6.1 Europe Neurocutaneous Disorder Revenue by Countries (2013-2018)
6.2 Germany Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
6.3 UK Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
6.4 France Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
6.5 Russia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
6.6 Italy Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC NEUROCUTANEOUS DISORDER REVENUE BY COUNTRIES

7.1 Asia-Pacific Neurocutaneous Disorder Revenue by Countries (2013-2018)
7.2 China Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
7.3 Japan Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
7.4 Korea Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
7.5 India Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA NEUROCUTANEOUS DISORDER REVENUE BY COUNTRIES

8.1 South America Neurocutaneous Disorder Revenue by Countries (2013-2018)
8.2 Brazil Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
8.3 Argentina Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
8.4 Colombia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE NEUROCUTANEOUS DISORDER BY COUNTRIES

9.1 Middle East and Africa Neurocutaneous Disorder Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
9.3 UAE Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
9.4 Egypt Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
9.6 South Africa Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)

10 GLOBAL NEUROCUTANEOUS DISORDER MARKET SEGMENT BY TYPE

10.1 Global Neurocutaneous Disorder Revenue and Market Share by Type (2013-2018)
10.2 Global Neurocutaneous Disorder Market Forecast by Type (2018-2023)
10.3 Tuberous Sclerosis (TS) Revenue Growth Rate (2013-2023)
10.4 Neurofibromatosis (NF) Revenue Growth Rate (2013-2023)
10.5 Sturge-Weber Syndrome Disease Revenue Growth Rate (2013-2023)
10.6 Von Hippel-Lindau Disease (VHL) Revenue Growth Rate (2013-2023)
10.7 Ataxia-Telangiectasia (A-T) Revenue Growth Rate (2013-2023)

11 GLOBAL NEUROCUTANEOUS DISORDER MARKET SEGMENT BY APPLICATION

11.1 Global Neurocutaneous Disorder Revenue Market Share by Application (2013-2018)
11.2 Neurocutaneous Disorder Market Forecast by Application (2018-2023)
11.3 Hospital & Clinics Revenue Growth (2013-2018)
11.4 Diagnostic Centers Revenue Growth (2013-2018)

12 GLOBAL NEUROCUTANEOUS DISORDER MARKET SIZE FORECAST (2018-2023)

12.1 Global Neurocutaneous Disorder Market Size Forecast (2018-2023)
12.2 Global Neurocutaneous Disorder Market Forecast by Regions (2018-2023)
12.3 North America Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
12.4 Europe Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
12.6 South America Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neurocutaneous Disorder Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neurocutaneous Disorder Picture
Table Product Specifications of Neurocutaneous Disorder
Table Global Neurocutaneous Disorder and Revenue (Million USD) Market Split by Product Type
Figure Global Neurocutaneous Disorder Revenue Market Share by Types in 2017
Figure Tuberous Sclerosis (TS) Picture
Figure Neurofibromatosis (NF) Picture
Figure Sturge-Weber Syndrome Disease Picture
Figure Von Hippel-Lindau Disease (VHL) Picture
Figure Ataxia-Telangiectasia (A-T) Picture
Table Global Neurocutaneous Disorder Revenue (Million USD) by Application (2013-2023)
Figure Neurocutaneous Disorder Revenue Market Share by Applications in 2017
Figure Hospital & Clinics Picture
Figure Diagnostic Centers Picture
Table Global Market Neurocutaneous Disorder Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Neurocutaneous Disorder Type and Applications
Table Valeant Pharmaceuticals Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Neurocutaneous Disorder Type and Applications
Table Allergan Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Syneron Medical Basic Information, Manufacturing Base and Competitors
Table Syneron Medical Neurocutaneous Disorder Type and Applications
Table Syneron Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Neurocutaneous Disorder Type and Applications
Table Medtronic Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Cutera Basic Information, Manufacturing Base and Competitors
Table Cutera Neurocutaneous Disorder Type and Applications
Table Cutera Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table St Jude Medical Basic Information, Manufacturing Base and Competitors
Table St Jude Medical Neurocutaneous Disorder Type and Applications
Table St Jude Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Neurocutaneous Disorder Type and Applications
Table Pfizer Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurocutaneous Disorder Revenue (Million USD) by Players (2013-2018)
Table Global Neurocutaneous Disorder Revenue Share by Players (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Share by Players in 2016
Figure Global Neurocutaneous Disorder Revenue Share by Players in 2017
Figure Global Top 5 Players Neurocutaneous Disorder Revenue Market Share in 2017
Figure Global Top 10 Players Neurocutaneous Disorder Revenue Market Share in 2017
Figure Global Neurocutaneous Disorder Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Neurocutaneous Disorder Revenue (Million USD) by Regions (2013-2018)
Table Global Neurocutaneous Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Market Share by Regions in 2017
Figure North America Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Europe Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure South America Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table North America Neurocutaneous Disorder Revenue by Countries (2013-2018)
Table North America Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Neurocutaneous Disorder Revenue Market Share by Countries in 2017
Figure USA Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Canada Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Mexico Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table Europe Neurocutaneous Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Europe Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure Europe Neurocutaneous Disorder Revenue Market Share by Countries in 2017
Figure Germany Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure UK Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure France Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Russia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Italy Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neurocutaneous Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Neurocutaneous Disorder Revenue Market Share by Countries in 2017
Figure China Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Japan Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Korea Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure India Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table South America Neurocutaneous Disorder Revenue by Countries (2013-2018)
Table South America Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Neurocutaneous Disorder Revenue Market Share by Countries in 2017
Figure Brazil Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Argentina Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Colombia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neurocutaneous Disorder Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurocutaneous Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurocutaneous Disorder Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure UAE Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Egypt Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure Nigeria Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Figure South Africa Neurocutaneous Disorder Revenue and Growth Rate (2013-2018)
Table Global Neurocutaneous Disorder Revenue (Million USD) by Type (2013-2018)
Table Global Neurocutaneous Disorder Revenue Share by Type (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Share by Type (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Share by Type in 2017
Table Global Neurocutaneous Disorder Revenue Forecast by Type (2018-2023)
Figure Global Neurocutaneous Disorder Market Share Forecast by Type (2018-2023)
Figure Global Tuberous Sclerosis (TS) Revenue Growth Rate (2013-2018)
Figure Global Neurofibromatosis (NF) Revenue Growth Rate (2013-2018)
Figure Global Sturge-Weber Syndrome Disease Revenue Growth Rate (2013-2018)
Figure Global Von Hippel-Lindau Disease (VHL) Revenue Growth Rate (2013-2018)
Figure Global Ataxia-Telangiectasia (A-T) Revenue Growth Rate (2013-2018)
Table Global Neurocutaneous Disorder Revenue by Application (2013-2018)
Table Global Neurocutaneous Disorder Revenue Share by Application (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Share by Application (2013-2018)
Figure Global Neurocutaneous Disorder Revenue Share by Application in 2017
Table Global Neurocutaneous Disorder Revenue Forecast by Application (2018-2023)
Figure Global Neurocutaneous Disorder Market Share Forecast by Application (2018-2023)
Figure Global Hospital & Clinics Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Neurocutaneous Disorder Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Neurocutaneous Disorder Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Neurocutaneous Disorder Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
Figure Europe Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
Figure South America Neurocutaneous Disorder Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Neurocutaneous Disorder Revenue Market Forecast (2018-2023)